We have recently described that Tau, a protein associated with neurodegenerative diseases, is also expressed in glioma cells, particularly in the less aggressive tumors, where it obstructs glioma progression by blocking the formation of novel and aberrant tumor vessels. This evidence concerns the gene MAPT and central nervous system cancer.